Posters

Visual and refractive outcomes after V4c ICL in 40 to 55 years old patients: one-year of follow-up.

Poster Details

First Author: P.Tañá-Rivero SPAIN

Co Author(s):    R. Montes-Mico   R. Ruíz-Mesa   M. Ruíz-Santos   S. Aguilar-Córcoles           

Abstract Details

Purpose:

To assess the efficacy, safety and predictability of the Visian Implantable Collamer Lens with a central port in patients between 40 and 55 years old.

Setting:

Oftalvist Clinic, Alicante (Spain)

Methods:

This retrospective study comprised 25 eyes who underwent implantation of the Visian Implantable Collamer Lens (ICL, model V4c, STAAR Surgical Inc) to correct myopia and astigmatism at Oftalvist Clinic , Spain. Standard values for uncorrected (UDVA) and corrected (CDVA) distance Snellen decimal visual acuities, refraction, intraocular pressure (IOP), endothelial cell density (ECD), vault and adverse events were evaluated over a 1-year period.

Results:

The mean age at the time of surgery was 43.2 years±4.14 (SD) (range 40 to 55 years). The mean preoperative spherical equivalent (SE) refractive error was -9.36±2.61 D (range from-1.50 to -14.88 D) and mean CDVA was 0.87±0.18. Mean ECD and IOP before the surgery were 2699±480 cell/mm2 and 16.59±3.75 mmHg, respectively. At 1 year, mean SE was -0.15±0.38D (range from 0.25 to -1.50D), and UDVA and CDVA were 0.90±0.16 and 0.96±0.06, respectively. Mean ECD was 2469±360 cell/mm2, mean IOP was 15.83±3.0 mmHg and mean vault was 331±120 μm. No adverse events were reported during the study.

Conclusions:

The good results reported in this study support the use of this phakic posterior intraocular lens in patients with 40-55 years old.

Financial Disclosure:

None